Cardiometabolic Role of Visfatin in Patients on Peritoneal Dialysis

Akarsu O., Baysal O., Karadag S., Gursu M., Ozkan O., Uzun S., ...Daha Fazla

TURKISH JOURNAL OF NEPHROLOGY, cilt.29, sa.4, ss.297-303, 2020 (ESCI, Scopus, TRDizin) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 4
  • Basım Tarihi: 2020
  • Doi Numarası: 10.5152/turkjnephrol.2020.4123
  • Dergi Adı: TURKISH JOURNAL OF NEPHROLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.297-303
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Objective: There is a relationship between inflammation and cardiovascular disease (CVD) in patients with chronic kidney disease. Visfatin is an adipocytokine, which has been shown to be associated with inflammation, endothelial dysfunction, and CVD. Our study aimed to examine the relationship of visfatin with metabolic and echocardiographic parameters in patients on peritoneal dialysis (PD).